Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Davidson

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|September 4, 2025
[Challenges concerning lymphadenopathy after COVID-19 vaccination]Linda Davidson, Cees van Nieuwkoop, Tamara N Platteel, et al.
Acta Dermato-Venereologica|January 28, 2022
Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance CenterLinda Davidson, Juul M P A Van den Reek, Florence Van Hunsel, et al.
Journal of Vascular Surgery|January 23, 2020
Index and follow-up costs of endovascular abdominal aortic aneurysm repair from the Endurant Stent Graft System Post Approval Study (ENGAGE PAS)Chun Li, Sarah E Deery, Eric L Eisenstein, et al.
Chest|February 1, 2020
Hospital-Based Resource Use and Costs Among Patients With Idiopathic Pulmonary Fibrosis Enrolled in the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) RegistryYanni Fan, Shaun D Bender, Craig S Conoscenti, et al.
The New England Journal of Medicine|September 5, 2008
Quality of life with defibrillator therapy or amiodarone in heart failureDaniel B Mark, Kevin J Anstrom, Jie L Sun, et al.
The Journal of Dermatological Treatment|December 22, 2022
Prevalence, risk and severity of SARS-CoV-2 infections in psoriasis patients receiving conventional systemic, biologic or topical treatment during the COVID-19 pandemic: a cross-sectional cohort study (PsoCOVID)Kevin V Kwee, Jean-Luc Murk, Qiqi Yin, et al.
JAMA Cardiology|May 25, 2017
Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial Infarction : A Secondary Analysis of the TRANSLATE-ACS StudyPatricia O Guimarães, Arun Krishnamoorthy, Lisa A Kaltenbach, et al.
Circulation|September 6, 2023
Cost-Effectiveness of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: The VICTORIA Randomized Clinical TrialDerek S Chew, Yanhong Li, Robert Bigelow, et al.
Journal of the American College of Cardiology|February 10, 2015
Economic analysis of ticagrelor therapy from a U.S. perspective: results from the PLATO studyPatricia A Cowper, Wenqin Pan, Kevin J Anstrom, et al.
Journal of the American Heart Association|January 27, 2016
How Reliable are Patient-Reported Rehospitalizations? Implications for the Design of Future Practical Clinical StudiesArun Krishnamoorthy, Eric D Peterson, J David Knight, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Nederlands Tijdschrift Voor Geneeskunde|September 4, 2025
[Challenges concerning lymphadenopathy after COVID-19 vaccination]Linda Davidson, Cees van Nieuwkoop, Tamara N Platteel, et al.
Acta Dermato-Venereologica|January 28, 2022
Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance CenterLinda Davidson, Juul M P A Van den Reek, Florence Van Hunsel, et al.
Journal of Vascular Surgery|January 23, 2020
Index and follow-up costs of endovascular abdominal aortic aneurysm repair from the Endurant Stent Graft System Post Approval Study (ENGAGE PAS)Chun Li, Sarah E Deery, Eric L Eisenstein, et al.
Chest|February 1, 2020
Hospital-Based Resource Use and Costs Among Patients With Idiopathic Pulmonary Fibrosis Enrolled in the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) RegistryYanni Fan, Shaun D Bender, Craig S Conoscenti, et al.
The New England Journal of Medicine|September 5, 2008
Quality of life with defibrillator therapy or amiodarone in heart failureDaniel B Mark, Kevin J Anstrom, Jie L Sun, et al.
The Journal of Dermatological Treatment|December 22, 2022
Prevalence, risk and severity of SARS-CoV-2 infections in psoriasis patients receiving conventional systemic, biologic or topical treatment during the COVID-19 pandemic: a cross-sectional cohort study (PsoCOVID)Kevin V Kwee, Jean-Luc Murk, Qiqi Yin, et al.
JAMA Cardiology|May 25, 2017
Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial Infarction : A Secondary Analysis of the TRANSLATE-ACS StudyPatricia O Guimarães, Arun Krishnamoorthy, Lisa A Kaltenbach, et al.
Circulation|September 6, 2023
Cost-Effectiveness of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: The VICTORIA Randomized Clinical TrialDerek S Chew, Yanhong Li, Robert Bigelow, et al.
Journal of the American College of Cardiology|February 10, 2015
Economic analysis of ticagrelor therapy from a U.S. perspective: results from the PLATO studyPatricia A Cowper, Wenqin Pan, Kevin J Anstrom, et al.
Journal of the American Heart Association|January 27, 2016
How Reliable are Patient-Reported Rehospitalizations? Implications for the Design of Future Practical Clinical StudiesArun Krishnamoorthy, Eric D Peterson, J David Knight, et al.
Pageof 5